Patel, 176 patient vitamin C late treatment study: 29% lower mortality [p=0.18] https://c19p.org/patel
copied to clipboard
The significance of oral ascorbic acid in patients with COVID-19
et al., Chest Infections, doi:10.1016/j.chest.2020.08.322
Retrospective 176 hospitalized patients, 96 treated with oral vitamin C (from 500mg to 1500mg daily), showing lower mortality with treatment.
|
risk of death, 29.5% lower, RR 0.71, p = 0.18, treatment 22 of 96 (22.9%), control 26 of 80 (32.5%), NNT 10.
|
|
risk of death, 15.6% lower, RR 0.84, p = 0.60, treatment 15 of 30 (50.0%), control 16 of 27 (59.3%), NNT 11, ICU patients.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Patel et al., 10/1/2020, retrospective, USA, North America, peer-reviewed, 8 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.